Ophinova
From Biomarker Discovery to Clinical Deployment
Industrializing Biomarkers into Clinical-Grade Diagnostics
We fast-track the translation of high-potential biomarkers into manufacturable IVD prototypes—ready for trials, scaling, and market impact.
• End-to-end support from feasibility to manufacturing
• Validated platforms, ISO-certified production, and real-world experience
About Ophinova
Ophinova is a specialized business unit of Ophiomics, focused on bringing biomarker discoveries into clinical and commercial reality.
We select high-potential diagnostic concepts and provide the full stack: advisory, prototyping, validation, and ISO-compliant manufacturing.
Whether you’re an academic innovator, startup founder, investor, or pharma team—we help you move fast and smart toward impactful diagnostic products.
What We Do
We provide:
Early-stage feasibility & advisory
Rapid prototyping on validated platforms
Clinical-grade IVD manufacturing & scale-up
Support for clinical deployment & trial integration
Our Platforms
NOLO‑Express
HYSEN‑Liquid
VST‑Box
Certifications: ISO 13485
Location: Lisbon, Portugal
Who We Work With
We partner with four strategic groups:
Tech Transfer Offices & Spinouts
“Cross the translational valley with confidence.”
We help academic discoveries become clinically and commercially viable.
- Feasibility and platform fit assessments
- Early product concepting and roadmap planning
- Market and regulatory pathway guidance
- Co-development and licensing options
Accelerators, Innovation Hubs & MedTech Investors
“Derisk and accelerate your portfolio.”
We prototype, validate, and help launch diagnostic concepts with real-world potential.
- Rapid turnaround from concept to IVD prototype (6–8 weeks)
- Diagnostic translation mentoring for startups
- Evidence packages for funding or scale
Pharma & Clinical Developers
“Enable smarter trials with deployable diagnostics.”
We manufacture trial-ready IVDs for patient recruitment, stratification, and endpoint enrichment
- Fit-for-purpose diagnostic kits
- Flexible deployment across sites
- Companion diagnostic development support.
Biotech Startups & Translational Teams
“Full-stack diagnostics without full-stack overhead.”
We provide the platforms, infrastructure, and expertise to move lean teams forward.
- Plug-and-play prototyping & validation
- Scalable production without internal labs
- Flexible IP, white-label, or co-brand options
Our Workflow
Feasibility Advisory
Evaluate biomarker fit, platform choice, and clinical utility
Prototype Development
Build functional assay on NOLO or HYSEN in under 6–8 weeks
Pilot Validation
Use real-world samples to assess performance
Kit Manufacturing
ISO-certified production of clinical-grade kits
Scale & Support
Deployment planning, regulatory pathways, and scale-up support
About Ophiomics
Ophinova is powered by Ophiomics, a European precision medicine company using genomics, AI, and data science to build better diagnostics. With a track record of innovation in oncology, platform engineering, and translational projects—we offer technical depth and operational credibility.
Based in Lisbon, operating across Europe and the Gulf.
